See you next year in Munich, Germany | September 16-18, 2026
Join us for RNA Horizons 2026, taking place September 16-18, 2026, in Munich, Germany. This premier event unites leading researchers to explore the latest RNA therapeutic advancements, from established modalities to emerging areas like ASOs and RNA structure-based therapies. Discussions will encompass key trends: pipeline diversification, enhanced RNA modalities, AI integration, and improved delivery technologies. Notably, the conference will address translating discoveries into viable therapies, exploring commercialization and market access.
Connect with leading scientists, clinicians and biotech innovators to explore the latest frontiers in RNA biology and therapeutic innovation.
This year’s conference will delve into the following key research areas:
- RNA Processing & Mis-Splicing in Human Disease
- Epitranscriptomic Regulation in Cancer, Immunity & Aging
- RNA-Based Immune Modulation
- mRNA Vaccines & Personalized RNA Immunotherapy
- RNA Therapeutics for Genetic & Rare Disorders
- RNA Biomarkers & Precision Medicine
- RNA-Mediated Tumor Microenvironment Modulation
- RNA Delivery Technologies
- Non-coding RNAs as Drug Targets
- AI in RNA Medicine
RNA Horizons 2026 Organizing Committee
Head of The Hadassah Cancer Research Institute (HCRI)
Hadassah Hebrew University Medical Center, Jerusalem, Israel
Head, Dermatology, Director of the Adaptive Resistance Team
Gustave Roussy and Paris Saclay University, France
Principal Investigator, The Guccione Lab
Icahn School of Medicine at Mount Sinai, USA
Principal Investigator
Catholic University of the Sacred Heart, School of Medicine, Italy
Our events
ORGANIZERS
RNA HORIZONS 2026 SPONSORS
2025 SPONSORS
2025 PARTICIPATING COMPANIES
